Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses.
Egger
Cornelia
C
Horak
Friedrich
F
Vrtala
Susanne
S
Valenta
Rudolf
R
Niederberger
Verena
V
D000281:Administration, Intranasal; D000328:Adult; D000485:Allergens / Q000276:immunology; D000917:Antibody Formation; D052179:Antigens, Plant / Q000276:immunology / Q000378:metabolism*; D029662:Betula / Q000276:immunology; D003888:Desensitization, Immunologic; D000939:Epitopes; D018984:Epitopes, T-Lymphocyte / Q000276:immunology / Q000378:metabolism*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D015508:Nasal Obstruction; D010446:Peptide Fragments / Q000276:immunology / Q000378:metabolism*; D011058:Pollen / Q000009:adverse effects; D011485:Protein Binding; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology
D000485:Allergens; D052179:Antigens, Plant; D000939:Epitopes; D018984:Epitopes, T-Lymphocyte; D010446:Peptide Fragments; D007073:Immunoglobulin E